SciGlo: A One-Stop Solution for Your Scientific and Career Needs By: Sandhya Sriram Ph.D. | Founder and C.E.O. of SciGlo 26 September 2017 Did you know that more than 65% of students/scientists spend more than 1 hour – 60 minutes! – per day online, searching for information (jobs, internships, products, reagents, labs, [..]
Summit LA17: The World’s Preeminent Ideas Festival November 3-6, 2017 — Downtown Los Angeles About the festival Summit’s 11th flagship, LA17, will gather 3,500 leaders across all disciplines. For three days, the festival will host a diverse array of talks, performances, wellness classes, art installations, gourmet food, and experiences designed [..]
Web Summit MEO ARENA, LISBON, NOVEMBER 6-9, 2017 What is Web Summit? Web Summit started as a simple idea in 2010: Let’s connect the technology community with all industries, both old and new. It seemed to resonate. Web Summit has grown to become the “largest technology conference in the world”. [..]
Rydapt® of Novartis Approved by EU for Acute Myeloid Leukemia (AML) and Systemic Mastocytosis (SM) By : Novartis News Novartis today announced that the European Commission (EC) approved Rydapt® (midostaurin) for two indications in rare, hard-to-treat cancers. Rydapt is approved for use in combination with standard daunorubicin and cytarabine induction and high-dose cytarabine [..]
First Duodenoscope With Disposable Distal Cap Got Clearance by FDA By: FDA News The U.S. Food and Drug Administration cleared the first duodenoscope with a disposable distal cap, a new feature that will improve access for cleaning and reprocessing. The Pentax ED34-i10T model duodenoscope is intended to provide visualization and [..]
Controlling Brain Cancer Growth By Neuroligin-3 Inhibition : Stanford Research By: Erin Digitale | Stanford News The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain’s nerve cells, according to a new study by researchers at the Stanford University [..]
Bio-Inspired Synthetic RNA Delivery System By: Anne Trafton | MIT News Office By delivering strands of genetic material known as messenger RNA (mRNA) into cells, researchers can induce the cells to produce any protein encoded by the mRNA. This technique holds great potential for administering vaccines or treating diseases such [..]
New FDA Approval to Bayer’s Copanlisib For Adults With Relapsed Follicular Lymphoma By: Bayer News Bayer Healthcare Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved copanlisib under the brand name Aliqopa™ 60 mg vial for injection for the treatment of adult patients with relapsed follicular lymphoma [..]
FDA Approved MVASI™ of Amgen And Allergan : First Biosimilar Treatment for Cancer By: Amgen News Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) announced that the U.S. Food and Drug Administration (FDA) has approved MVASI™ (bevacizumab-awwb) for all eligible indications of the reference product, Avastin® (bevacizumab). MVASI is the first anti-cancer biosimilar, as well [..]
50 Life Mantras by Dalai Lama By: Vijay Soni, Ph.D. | Founder and C.E.O. Scipreneur The Dalai Lama, his holiness is a world leader that is committed to promoting positive values such as, forgiveness, self-discipline, tolerance, compassion, and contentment. He is a spiritual leader like no other and is highlighting [..]
FDA Breakthrough Therapy Designation: To Cemiplimab (REGN2810) of Regeneron and Sanofi Source: Regeneron Pharmaceuticals, Inc. News Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation status to cemiplimab (REGN2810) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (CSCC) and adults with locally advanced [..]
The 4th Annual U.Pitch National Elevator Pitch Competition and Showcase November 16, 2017 Future Founders immerses youth in experiences that inspire and empower them to create their own opportunity. We believe this leads to a generation more determined, hopeful and equipped as they engage the future. To date, our programs have [..]
New England Venture Summit: 2017 Where Innovation Meets Capital™ Dec 6th, 2017 Lombardo’s Conference Center, Boston Randolph, MA, USA Early Bird Special Register Now and Save 50% youngStartup‘s Venture Summits connect the most innovative, promising [..]
Eterna: Online Game Challenges To Design On/Off Switch for CRISPR By: Jennie Dusheck | Stanford News A team of researchers at the Stanford University School of Medicine has launched a new challenge for the online computer game Eterna in which players are being asked to design an RNA molecule capable of acting as an on/off [..]
New Solar Cell Inspired By Insect Eyes: Perovskite Based Photovoltaics By: Mark Shwartz | Stanford News Packing tiny solar cells together, like micro-lenses in the compound eye of an insect, could pave the way to a new generation of advanced photovoltaics, say Stanford University scientists. In a new study, the Stanford [..]
Copyright © 2024 | WordPress Theme by MH Themes